Table 3.
Virus |
Mean IC50 [nm][a] |
|||||||
---|---|---|---|---|---|---|---|---|
Cell type |
SQV |
RTV |
IDV |
NFV |
APV |
AZT |
DRV (2) |
|
HIV‐1Ba‐L |
PBMC |
18 |
39 |
25 |
17 |
26 |
9 |
3 |
HIV‐2ROD |
MT‐2 |
3 |
130 |
14 |
19 |
230 |
18 |
3 |
HIV‐2EHO |
MT‐2 |
6 |
240 |
11 |
29 |
170 |
11 |
6 |
[a] All assays were conducted in duplicate or triplicate; the data represent mean IC50 values from three independent experiments. IC50 were evaluated with PHA‐PBMC and the inhibition of p24 Gag protein production by the drug as an end point. MT‐2 cells were exposed to the virus and cultured, and IC50 values were determined by MTT assay. See references 82 and 105 for details.